Amalgamated Bank’s Gilead Sciences Inc Position
Does Amalgamated Bank own Gilead Sciences Inc (GILD)? Yes — 239.2K shares worth $33M (+0.26% of its 13F portfolio) as of Q1 2026, down from 240.3K shares the prior filed quarter.
Position Value
$33M
Q1 2026
Shares
239.2K
% of Portfolio
+0.26%
Quarters Held
29
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 239.2K | $33M | +0.26% |
| Q4 2025 | 240.3K | $29M | +0.21% |
| Q3 2025 | 268.0K | $30M | +0.21% |
| Q2 2025 | 270.9K | $30M | +0.23% |
| Q1 2025 | 248.0K | $28M | +0.24% |
| Q4 2024 | 246.0K | $23M | +0.19% |
| Q3 2024 | 244.8K | $21M | +0.17% |
| Q2 2024 | 251.9K | $17M | +0.15% |
| Q1 2024 | 258.2K | $19M | +0.16% |
| Q4 2023 | 300.8K | $24M | +0.19% |
| Q3 2023 | 319.9K | $24M | +0.20% |
| Q2 2023 | 335.1K | $26M | +0.21% |
| Q1 2023 | 346.4K | $29M | +0.24% |
| Q4 2022 | 327.4K | $28M | +0.25% |
| Q3 2022 | 330.2K | $20M | +0.20% |
| Q2 2022 | 323.3K | $20M | +0.19% |
| Q1 2022 | 315.5K | $19M | +0.15% |
| Q4 2021 | 338.0K | $25M | +0.18% |
| Q3 2021 | 339.8K | $24M | +0.20% |
| Q2 2021 | 352.7K | $24M | +0.19% |
| Q1 2021 | 68.6K | $4M | +0.17% |
| Q4 2020 | 71.1K | $4M | +0.16% |
| Q3 2020 | 71.3K | $5M | +0.20% |
| Q2 2020 | 72.8K | $6M | +0.26% |
| Q1 2020 | 190.8K | $14M | +0.35% |
| Q4 2019 | 198.1K | $13M | +0.24% |
| Q3 2019 | 184.4K | $12M | +0.25% |
| Q2 2019 | 181.4K | $12M | +0.29% |
| Q1 2019 | 186.4K | $12M | +0.29% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amalgamated Bank’s full portfolio or all institutional holders of GILD.